Pelthos Therapeutics PTHS
NYSE PTHS
$18.71 -1.79 (-8.72%)
As of: Oct 21, 2026 · 3:59 PM EDT

Pelthos Therapeutics (PTHS) Net Margin (2025 - 2026)

Updated

Pelthos Therapeutics' Net Margin was -150.08% in Q2 2026, up 79.82 percentage points from the prior quarter.

Analysis

Pelthos Therapeutics (PTHS) Net Margin (2025 - 2026) Analysis & Trends

On a trailing twelve-month basis, Pelthos Therapeutics' Net Margin was -199.50% through Jun 30, 2026; for FY2025, it came in at -257.93%.

  • Per Business Quant data, PTHS's Net Margin in the three quarters before Q2 2026 was -229.90% (Q1 2026), -230.74% (Q4 2025) and -219.25% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 30.88%
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 21.86%
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 21.27%
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -8.04%
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 22.65%
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 16.30%
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 23.62%
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -134.51%
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -1.65%
10 Pelthos Therapeutics 67.89 Mn -20.51 Mn 11.99 Mn -150.08%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -150.08%
Mar 31, 2026 -229.90%
Dec 31, 2025 -230.74%
Sep 30, 2025 -219.25%
API Access

Pelthos Therapeutics Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=PTHS&period=max&api_key=YOUR_API_KEY